FIELD: biotechnology.
SUBSTANCE: invention relates to immunology and biotechnology. Disclosed is a recombinant C5 antibody comprising a variant Fc of a native wild type Fc IgG1 polypeptide, wherein said version includes 428L/434S/259I, and numbering is given according to EU index. Described are a coding nucleic acid, an expression vector and a host cell for antibody expression based on said vector. Also described is a method for producing the antibody by culturing said cell.
EFFECT: use of the invention provides higher binding of mouse or human to FcRn, as compared to native Fc IgG1 polypeptide, which can find application in medicine.
6 cl, 23 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
Fc VERSIONS WITH MODIFIED BINDING WITH FcRn | 2008 |
|
RU2529951C2 |
Fc-VERSIONS WITH ALTERED BINDING WITH FcRn | 2008 |
|
RU2517621C2 |
DESIGNED IL-2-FC FUSION PROTEINS | 2018 |
|
RU2812283C2 |
VERSIONS OF IMMUNOGLOBULIN AND THEIR APPLICATION | 2009 |
|
RU2536937C2 |
Fc-VERSIONS WITH CHANGED BINDING WITH FcRn | 2005 |
|
RU2412200C2 |
Fc-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE | 2014 |
|
RU2687043C2 |
POLYPEPTIDE VARIANTS WITH CHANGED EFFECTOR FUNCTION | 2005 |
|
RU2367667C2 |
OPTIMIZED Fc-VERSIONS THAT HAVE ALTERED BINDING TO FcγR AND METHODS FOR THEIR PRODUCTION | 2004 |
|
RU2337107C2 |
AFFINITY CHROMATOGRAPHY WITH APPLICATION OF Fc-RECEPTORS | 2013 |
|
RU2624128C2 |
VARIANTS WITH Fc-FRAGMENT, HAVING HIGH AFFINITY TO FcRn AND HIGH AFFINITY TO AT LEAST ONE RECEPTOR OF Fc-FRAGMENT | 2018 |
|
RU2820162C2 |
Authors
Dates
2019-09-23—Published
2014-07-25—Filed